within Pharmacolibrary.Drugs.ATC.N;

model N06DX02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 5e-05,
    adminDuration  = 600,
    adminMass      = 120 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0033333333333333335,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N06DX02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ginkgo folium refers to the dried leaves of the Ginkgo biloba tree and is used primarily as a herbal supplement. It is widely promoted for its potential cognitive-enhancing properties, and has been investigated for improvement of memory decline, dementia, and peripheral vascular diseases. Ginkgo folium is not universally approved as a pharmaceutical drug but is available as an over-the-counter supplement in many countries.</p><h4>Pharmacokinetics</h4><p>No comprehensive population pharmacokinetic studies exist for the whole Ginkgo folium formulation. Most available pharmacokinetic data pertain to constituents of Ginkgo biloba extract (such as ginkgolides and bilobalide) in healthy adult volunteers upon oral administration.</p><h4>References</h4><ol><li><p>Li, Z, et al., &amp; Huang, Y (2021). Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease. <i>Journal of ethnopharmacology</i> 280 114469–None. DOI:<a href=\"https://doi.org/10.1016/j.jep.2021.114469\">10.1016/j.jep.2021.114469</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34329714/\">https://pubmed.ncbi.nlm.nih.gov/34329714</a></p></li><li><p>Qu, C, et al., &amp; Yang, H (2022). Target profiling of flavonol glycosides in the extract of Ginkgo biloba leaf and their pharmacokinetics in rat plasma by ultra-high-performance liquid chromatography with tandem mass spectrometry. <i>Journal of separation science</i> 45(3) 728–738. DOI:<a href=\"https://doi.org/10.1002/jssc.202100744\">10.1002/jssc.202100744</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34841683/\">https://pubmed.ncbi.nlm.nih.gov/34841683</a></p></li><li><p>Chen, F, et al., &amp; Li, C (2013). Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration. <i>British journal of pharmacology</i> 170(2) 440–457. DOI:<a href=\"https://doi.org/10.1111/bph.12285\">10.1111/bph.12285</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23808355/\">https://pubmed.ncbi.nlm.nih.gov/23808355</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N06DX02;
